Drug Shortage Report for RIVA-LATANOPROST

Last updated on 2023-05-02 History
Report ID 161818
Drug Identification Number 02341085
Brand name RIVA-LATANOPROST
Common or Proper name Riva-Latanoprost opht.50mcg / ml 2.5ml
Company Name LABORATOIRE RIVA INC.
Market Status MARKETED
Active Ingredient(s) LATANOPROST
Strength(s) 50MCG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 2.5 ml
ATC code S01EE
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-06-10
Actual start date 2022-08-05
Estimated end date 2022-10-31
Actual end date 2022-11-18
Shortage status Resolved
Updated date 2023-05-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 660 BOUL. INDUSTRIEL
BLAINVILLE, QUEBEC
CANADA J7C 3V4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-05-02 French Compare
v6 2023-05-02 English Compare
v5 2022-08-16 French Compare
v4 2022-08-16 English Compare
v3 2022-06-11 English Compare
v2 2022-06-03 French Compare
v1 2022-06-03 English Compare

Showing 1 to 7 of 7